Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Endroit courant :
> This Story

Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment




Business Affairs Homepage

Johnson & Johnson to acquire Auris Health for $3.4 billion With possible $2.35 billion added if certain milestones are hit

Asheville Radiology Association joins Strategic Radiology The latest expansion by the imaging coalition brings 43 new physicians to the table

Maybe competition is good for what 'ails' hospitals Mergers may be good for business, but what about patients?

Frost & Sullivan outline 10 growth factors for precision imaging market Market predicted to be more than $8 billion by 2027

RadNet buys Kern Radiology The Bakersfield, California imaging group includes four offices

More of GE healthcare unit could be on block: CEO CEO Culp speaks in post-earnings call after company exceeds Q4 expectations

Philips, Lunit, Vuno in healthcare AI deal Forging partnerships to advance AI applications

Trade war forcing Philips to move production between US, China CEO van Houten addresses company growth in earnings call

Aetna, Anthem, Health Care Service, PNC Bank and IBM collaborate on healthcare blockchain 'ecosystem' Increasing industry transparency

Clinical wearables – remaining competitive in an evolving market Insights from Ravi Kuppuraj, Business Leader of Connected Sensing Venture for Philips

GE Healthcare, Lantheus start second Flurpiridaz phase 3 clinical trial

par Thomas Dworetzky , Contributing Reporter
GE Healthcare and Lantheus have begun a second Phase 3 clinical trial of Flurpiridaz 18F to detect coronary artery disease (CAD).

CAD strikes nearly 15.5 million Americans over 20 years of age, and is the number one cause of death in the U.S. and Europe.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510

The study, called AURORA, is looking at the efficacy of Flurpiridaz 18F injection positron-emission tomography (PET) myocardial perfusion imaging (MPI) to spot the disease.

“The second Phase 3 study of Flurpiridaz 18F represents a significant milestone in the development of this promising investigational agent. Importantly, it illustrates our strong collaboration with GE Healthcare, and we look forward to the continued progress of the clinical program,” Lantheus president and CEO Mary Anne Heino said in a statement.

The AURORA study enrolled its first patient in 2018 and will sign up a total of patients for the trial, during which they will be followed to 2020.

“We are thrilled to see this critical stage of the study move forward,” said Kevin O’Neill, general manager of Core Imaging for GE Healthcare.”

In mid-2017 GE Healthcare and Lantheus had agreed to continue phase 3 development and global commercialization of flurpiridaz F 18.

Flurpiridaz F 18 is a fluorine 18-labeled PET agent with a 110-minute half-life that can be used together with treadmill exercise, which is not feasible with other PET tracers, for myocardial perfusion imaging.

The first phase 3 study, which was announced in May 2015, found that flurpiridaz F 18 improved CAD detection and reduced radiation exposure compared to SPECT imaging. Subgroup analyses revealed that flurpiridaz F 18 PET imaging seems to work best in women, obese patients and those with multi-vessel disease.

GE has been much in the news over its moves to reposition itself. In its latest efforts to shed non-core holdings, in July, private equity firm Veritas Capital and GE Healthcare closed their $1 billion deal announced in April.

The move is part of a dramatic time, including the spinning off of GE Healthcare, announced in late June, as the final major deal designed to cut debt, simplify company structure, and raise cash. These have included spinning off its train manufacturing business and the $3.3 billion sale of its distributed power division.

Plans also call for selling off shares of its ownership in oil services company Baker Hughes over the next two to three years.

“We are aggressively driving forward as an aviation, power and renewable energy company – three highly complementary businesses poised for future growth. We will continue to improve our operations and balance sheet as we make GE simpler and stronger,” CEO John Flannery said at the time.

The buy was called “an exciting chapter” by Veritas Capital CEO and managing partner Ramzi Musallam in a statement.

When the deal was announced in April, he had called the opportunities in the $9 billion healthcare tech market “tremendous.”

Beyond the IT assets, the entire GE Healthcare enterprise includes magnetic imaging, medical diagnostics and drug discovery. The healthcare unit pulled in just 16 percent of companywide sales last year, adding up to $19.1 billion.

Business Affairs Homepage

You Must Be Logged In To Post A Comment

Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2019 DOTmed.com, Inc.